Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Many Bright Ideas Technologies Inc V.MBI.H

Alternate Symbol(s):  MBGNF

Many Bright Ideas Technologies Inc. is a Canada-based company. The Company is focused on commercializing alternative non-medical technologies. It has not generated any revenue.


TSXV:MBI.H - Post by User

Post by readytogo1on Jun 19, 2013 11:06pm
244 Views
Post# 21546191

Interesting Article

Interesting Article

For those people that are questioning whether commercialisation will be achieved or not I find this article interesting. It describes the basis of the lawsuit filed by Signal Genetics Respira against Med and Precision. Signal in their offer to Med claimed that commercialisation would take place within 90 days of a deal being signed. That would suggest that Signal must have felt that getting this test commercialised was not going to be a difficult task. The lawsuit claims that Precision approached Signal's marketer to get them on board with Precision.

https://www.genengnews.com/gen-news-highlights/tussle-between-respira-and-b-precision-b-for-med-biogene-s-nsclc/81244866/

Bullboard Posts